US 10196443
TEM8 antibodies and their use in treatment and detection of tumors
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 10196443 (TEM8 antibodies and their use in treatment and detection of tumors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K39/39558, A61K45/06